$IMMU Moore Kuehn Encourages IMMU, ONDK, VRTU, and OTEL Investors to Contact Law Firm

on September 15, 2020 News and Tags: , , , , , , , , , , , , , , , with 0 comments

NEW YORK, Sept. 15, 2020 /PRNewswire/ -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies:

Immunomedics, Inc. (NASDAQ: IMMU)

Immunomedics has agreed to be acquired by Gilead Sciences. Under the proposed transaction, shareholders of Immunomedics will receive $88.00 in cash for every share owned.

On Deck Capital, Inc. (NYSE: ONDK)

A registration statement was recently filed with the SEC regarding Enova International's acquisition of On Deck. Upon completion of the merger, shareholders of On Deck will receive $0.12 per share in cash and 0.092 shares of Enova for every share owned. The investigation concerns whether On Deck's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price.

Virtusa Corporation (NASDAQ: VRTU)

Virtusa has agreed to be acquired by Baring Private Equity Asia. Under the proposed transaction, shareholders of Virtusa will receive $51.35 in cash for every share owned.

Otelco, Inc. (NASDAQ: OTEL)

A proxy was recently filed with the SEC regarding Oak Hill Capital's acquisition of Otelco, which may omit material information regarding the financial metrics and analyses used to evaluate the merger. Under the proposed transaction, shareholders of Otelco will receive $11.75 for every share owned.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.

Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com or telephone at (212) 709-8245. The consultation and case are free with no obligation to you. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Moore Kuehn is a 5-star New York City-based law firm with attorneys representing investors and consumers in class action litigation involving securities law violations, financial fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please go to http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
(212) 709-8245

View original content to download multimedia:http://www.prnewswire.com/news-releases/moore-kuehn-encourages-immu-ondk-vrtu-and-otel-investors-to-contact-law-firm-301131567.html

SOURCE Moore Kuehn, PLLC

Get the Latest IMMU - Immunomedics, Inc. News & Updates!